Search Results - "Januszewski, Adam"

ERWACHSENE ALS SICHERE STÜTZE: Selbstverletzung bei Jugendlichen – Kampf um Aufmerksamkeit oder ein Hilfeschrei?

Authors: Januszewski, Adam

Source: Praxis Kommunikation. jun/jul2024, Issue 3, p8-10. 3p.

Long term efficacy of first-line afatinib and the clinical utility of ctDNA monitoring in patients with suspected or confirmed EGFR mutant non-small cell lung cancer who were unsuitable for chemotherapy: Clinical Studies.

Authors: Popat, Sanjay Januszewski, Adam O'Brien, Mary et al.

Source: British Journal of Cancer. Feb2025, Vol. 132 Issue 3, p245-252. 8p.

163 - A rare case of primary pulmonary NUT carcinoma with vertebral metastasis.

Authors: Ghose, Aruni Januszewski, Adam Giaslakiotis, Konstantinos et al.

Source: Lung Cancer (01695002). 2022 Supplement 1, Vol. 165, pS75-S76. 2p.

Genetic Analysis of Acral Melanomas From Southern African Patients.

Authors: Tod, Bianca Nam, Yoonhee Kaya, Deniz Ece et al.

Source: Pigment Cell & Melanoma Research. Jul2026, Vol. 39 Issue 4, p1-12. 12p.

Translation approaches to support systemic anti-cancer therapy consent for individuals with limited English proficiency.

Authors: Hibbs, Stephen P. Nizam, Rumman Tanzim, Ubaid et al.

Source: Supportive Care in Cancer. Apr2026, Vol. 34 Issue 4, p1-10. 10p.

Understanding the impact of distance and disadvantage on lung cancer care and outcomes: a study protocol.

Authors: McInnerney, Daisy Quaife, Samantha L. Cooke, Samuel et al.

Source: BMC Cancer. 8/2/2024, Vol. 24 Issue 1, p1-9. 9p.

Investigating the role of genomic drivers of MET pathway dysregulation in the heterogeneity of pleomorphic lung carcinoma

Authors: Januszewski, Adam

Committee Members: Bowcock, Anne; Popat, Sanjay

URL: https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.806559

Hyperthermia in cancer: is it coming of age?

Authors: Januszewski, Adam Stebbing, Justin

Source: Lancet Oncology. May2014, Vol. 15 Issue 6, p565-566. 2p.

Correlation between BAP1 Localization, Driver Mutations, and Patient Survival in Uveal Melanoma.

Authors: Cole, Yasemin C. Zhang, Yu-Zhi Gallo, Beatrice et al.

Source: Cancers. Sep2022, Vol. 14 Issue 17, p4105. 13p.

Breast cancer: Current and future endocrine therapies.

Authors: Palmieri, Carlo Patten, Darren K. Januszewski, Adam et al.

Source: Molecular & Cellular Endocrinology. Jan2014, Vol. 382 Issue 1, p695-723. 29p.

An Association of Cancer Physicians' strategy for improving services and outcomes for cancer patients.

Authors: Baird, Richard Banks, Ian Cameron, David et al.

Source: Ecancermedicalscience. 2016, Vol. 10 Issue 608-629, p1-58. 58p.

162 - Opsoclonus myoclonus syndrome in small cell lung cancer: a diagnostic challenge.

Authors: Ghose, Aruni Thyagarajan, Revathy Januszewski, Adam et al.

Source: Lung Cancer (01695002). 2022 Supplement 1, Vol. 165, pS75-S75. 1p.

96 - Evaluating the need for, and provision of, a dietetic service in patients with early-stage lung cancer.

Authors: Desmond, Nicole Biglin, Sarah Leggett, John et al.

Source: Lung Cancer (01695002). 2023 Supplement 1, Vol. 178, pS41-S42. 2p.

207 Exploring the experiences of rural and coastal people with lung cancer and their informal carers' in accessing and engaging in treatment: A qualitative interview study.

Authors: Cooke, Samuel Mitchinson, Lucy McInnerney, Daisy et al.

Source: Lung Cancer (01695002). 2024 Supplement 1, Vol. 190, pN.PAG-N.PAG. 1p.

110 Co-creating a psychological prehabilitation document for people preparing for lung cancer treatments.

Authors: Dancyger, Caroline Renouf, Philippa Ricketts, William et al.

Source: Lung Cancer (01695002). 2024 Supplement 1, Vol. 190, pN.PAG-N.PAG. 1p.

101 Real-world analysis of the impact of pemetrexed in first-line maintenance (1LM) with immunotherapy (IO) for non-squamous (NSQ) advanced/metastatic non-small cell lung cancer (a/mNSCLC) lacking targetable mutations, prior to and during the COVID-19 pandemic

Authors: Gomes, Fabio Gilding, Niall Tan, Vivian et al.

Source: Lung Cancer (01695002). 2024 Supplement 1, Vol. 190, pN.PAG-N.PAG. 1p.

21 Barriers to and facilitators of patient engagement in the lung cancer pathway: An interview study exploring the impact of distance and disadvantage in an urban setting.

Authors: Mitchinson, Lucy Quaife, Samantha Nelson, David et al.

Source: Lung Cancer (01695002). 2024 Supplement 1, Vol. 190, pN.PAG-N.PAG. 1p.

14 Widening access and addressing inequalities for patients with lung cancer consenting to systemic anti-cancer therapies (SACT).

Authors: Nally, Elizabeth Reeves, Annie Lerner, Anna et al.

Source: Lung Cancer (01695002). 2024 Supplement 1, Vol. 190, pN.PAG-N.PAG. 1p.

2 The role of cellular pathology departments in the improvement of turnaround times for lung adenocarcinoma biomarker testing.

Authors: Warren, Madhuri V Farooque, Taiba Rodgers, Stephen et al.

Source: Lung Cancer (01695002). 2024 Supplement 1, Vol. 190, pN.PAG-N.PAG. 1p.

Dexmedetomidine Attenuates Isoflurane-induced Neurocognitive Impairment in Neonatal Rats.

Authors: Sanders, Robert D. Jing Xu Yi Shu et al.

Source: Anesthesiology. May2009, Vol. 110 Issue 5, p1077-1085. 9p. 3 Graphs.